TY - JOUR
T1 - 2,5-Diketopiperazines
T2 - A Review of Source, Synthesis, Bioactivity, Structure, and MS Fragmentation
AU - Jia, Jia
AU - Yao, Jianling
AU - Kong, Jiao
AU - Yu, Axiang
AU - Wei, Jing
AU - Dong, Ying
AU - Song, Ruolan
AU - Shan, Dongjie
AU - Zhong, Xiangjian
AU - Lv, Fang
AU - Fan, Qiqi
AU - She, Gaimei
N1 - Publisher Copyright:
© 2023 Bentham Science Publishers.
PY - 2023
Y1 - 2023
N2 - Background: 2,5-Diketopiperazines (DKPs), also called cyclic dipeptides, are the simplest peptide derivatives in nature that are formed by the condensation of two ami-no acids. They are an important category of bioactive substances with various structures. Objective: This review focuses on the natural sources, synthetic processes, biological properties and MS fragmentation regularity of simple DKPs, in order to provide a refer-ence for exploring future scientific and therapeutic potentials of these compounds. Methods: Pertinent information was collected and organized from several electronic scientific databases (e.g., Web of Science, China Knowledge Resource Integrated, Sci-enceDirect, PubMed, Wanfang Data and Google Scholar), PhD and MS dissertations. There are 107 articles published from the early 20th century to 2021 that were reviewed in this work. Results: DKPs have been obtained from a broad range of natural resources, including fun-gi, bacteria, plants, and animals, and have been synthesized by chemical and biological methods. DKPs have various pharmacological activities, including anticancer, antibacte-rial, antithrombotic, neuron protective, analgesic, and other activities. Mass spectrometry is the most common method for the structural analysis of DKPs. DKPs can be quickly screened and identified by MS according to the mass spectrum fragmentation pattern. Conclusion: As a category of relatively unexplored compounds, DKPs have been demon-strated to have various bioactivities, especially with antitumor and antibacterial activities. However, the existing research on DKPs is still in the early stage, and their application in drug development needs to be further studied.
AB - Background: 2,5-Diketopiperazines (DKPs), also called cyclic dipeptides, are the simplest peptide derivatives in nature that are formed by the condensation of two ami-no acids. They are an important category of bioactive substances with various structures. Objective: This review focuses on the natural sources, synthetic processes, biological properties and MS fragmentation regularity of simple DKPs, in order to provide a refer-ence for exploring future scientific and therapeutic potentials of these compounds. Methods: Pertinent information was collected and organized from several electronic scientific databases (e.g., Web of Science, China Knowledge Resource Integrated, Sci-enceDirect, PubMed, Wanfang Data and Google Scholar), PhD and MS dissertations. There are 107 articles published from the early 20th century to 2021 that were reviewed in this work. Results: DKPs have been obtained from a broad range of natural resources, including fun-gi, bacteria, plants, and animals, and have been synthesized by chemical and biological methods. DKPs have various pharmacological activities, including anticancer, antibacte-rial, antithrombotic, neuron protective, analgesic, and other activities. Mass spectrometry is the most common method for the structural analysis of DKPs. DKPs can be quickly screened and identified by MS according to the mass spectrum fragmentation pattern. Conclusion: As a category of relatively unexplored compounds, DKPs have been demon-strated to have various bioactivities, especially with antitumor and antibacterial activities. However, the existing research on DKPs is still in the early stage, and their application in drug development needs to be further studied.
KW - 2,5-Diketopiperazines
KW - bioactivity
KW - cyclic dipeptides
KW - fragmentation
KW - mass spectrometry
KW - mass spectrum fragmentation pattern
UR - http://www.scopus.com/inward/record.url?scp=85147506747&partnerID=8YFLogxK
U2 - 10.2174/0929867329666220801143650
DO - 10.2174/0929867329666220801143650
M3 - Review article
C2 - 35927899
AN - SCOPUS:85147506747
SN - 0929-8673
VL - 30
SP - 1060
EP - 1085
JO - Current Medicinal Chemistry
JF - Current Medicinal Chemistry
IS - 9
ER -